Funding for this research was provided by:
The Loop Zurich (Grant number)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (196140)
Received: 6 May 2022
Accepted: 30 September 2022
First Online: 17 November 2022
: The local ethics committee approved this study (Ethikkommission Nordwest- und Zentralschweiz, BASEC #2020-01311). All patients or their legal representative gave their consent to participate in the study.
: Not applicable.
: JCS and TS report grants (full departmental disclosure) from Orion Pharma, Abbott Nutrition International, B. Braun Medical AG, CSEM AG, Edwards Lifesciences Services GmbH, Kenta Biotech Ltd, Maquet Critical Care AB, Omnicare Clinical Research AG, Nestle, Pierre Fabre Pharma AG, Pfizer, Bard Medica S.A., Abbott AG, Anandic Medical Systems, Pan Gas AG Healthcare, Bracco, Hamilton Medical AG, Fresenius Kabi, Getinge Group Maquet AG, Dräger AG, Teleflex Medical GmbH, Glaxo Smith Kline, Merck Sharp and Dohme AG, Eli Lilly and Company, Baxter, Astellas, Astra Zeneca, CSL Behring, Novartis, Covidien, Phagenesis, Nycomed and Cytel outside the submitted work. The money went into departmental funds. No personal financial gain applied. GMK reports grant from Janssen-Cilag. The payment went into institution funds and is unrelated to this work. VRZ report grants from EU Gender Academy, Bundesministerium für Bildung und Forschung, Springer, Novartis, Pfizer, Lilly, AbbVie and Paul Martini Foundation. The payment went into institution funds and is unrelated to this work. GH is an associate editor of BMC Diagnsotic and Prognostic Research. All other authors declare no competing interests.